反応式
[N:1]1[C:5]2[CH:6]=[CH:7][C:8]([NH2:10])=[CH:9][C:4]=2[NH:3][CH:2]=1.[CH3:11][O:12][C:13]1[CH:20]=[CH:19][C:16]([CH2:17]Br)=[CH:15][CH:14]=1.[C:21]([O-:24])([O-])=O.[K+].[K+]>>[CH3:11][O:12][C:13]1[CH:20]=[CH:19][C:16]([CH2:17][N:10]([CH2:17][C:16]2[CH:19]=[CH:20][C:13]([O:24][CH3:21])=[CH:14][CH:15]=2)[C:8]2[CH:7]=[CH:6][C:5]3[NH:1][CH:2]=[N:3][C:4]=3[CH:9]=2)=[CH:15][CH:14]=1参加物
4
実験手順
The compound was synthesized starting from benzimidazol-5-amine (133 mg; 1 mmol; 1 eq.), 4-methoxybenzylbromide (442 mg; 0.317 ml; 2.2 mmol; 2.2 eq.) and K2CO3 (304 mg; 2.2 mmol; 2.2 eq.) according to method 5; Yield: 0.137 mg (36.7%); MS m/z: 374.1 [M+H]+; 1H-NMR (500 MHz, DMSO d6): δ 3.70 (s, 6H), 4.54 (s, 4H); 6.71 (d, 1H, 4J=2.2 Hz); 6.78 (dd, 1H, 4J=2.4 Hz, 3J=8.9 Hz); 6.84-6.87 (m, 4H); 7.17-7.20 (m, 4H); 7.33 (d, 1H, 3J=8.9 Hz); 7.93 (s, 1H); 12.03 (br s, 1H); HPLC (METHOD [A]): rt 15.56 min (99.5%)
後処理
- customThe compound was synthesized
- customrt 15.56 min (99.5%)
出典と根拠
- ORDレコード
- ord-83c4d064c3444340b1b4650baa21edde
- 出典データセット
- uspto-grants-2013_09
- 特許番号
- US08541596B2
関連ノート
読み込み中…